Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer.

MLA

Lucchetti, Donatella, et al. “Mutational Status of Plasma Exosomal KRAS Predicts Outcome in Patients with Metastatic Colorectal Cancer.” Scientific Reports, vol. 11, no. 1, Nov. 2021, p. 22686. EBSCOhost, https://doi.org/10.1038/s41598-021-01668-7.

APA

Lucchetti, D., Zurlo, I. V., Colella, F., Ricciardi-Tenore, C., Di Salvatore, M., Tortora, G., De Maria, R., Giuliante, F., Cassano, A., Basso, M., Crucitti, A., Laurenzana, I., Artemi, G., & Sgambato, A. (2021). Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer. Scientific Reports, 11(1), 22686. https://doi.org/10.1038/s41598-021-01668-7

Chicago

Lucchetti, Donatella, Ina Valeria Zurlo, Filomena Colella, Claudio Ricciardi-Tenore, Mariantonietta Di Salvatore, Giampaolo Tortora, Ruggero De Maria, et al. 2021. “Mutational Status of Plasma Exosomal KRAS Predicts Outcome in Patients with Metastatic Colorectal Cancer.” Scientific Reports 11 (1): 22686. doi:10.1038/s41598-021-01668-7.